Showing results (1501-1510 of 1,709) with videos related to

Sort By:
Pageof 171
Journal of Tissue Engineering|August 25, 2017
A quantitative, multi-national and multi-stakeholder assessment of barriers to the adoption of cell therapiesBenjamin M Davies, James Smith, Sarah Rikabi, et al.
Investigative Ophthalmology & Visual Science|December 22, 2012
A genetic case-control study confirms the implication of SMAD7 and TNF locus in the development of proliferative vitreoretinopathyJimena Rojas, Itziar Fernandez, Jose C Pastor, et al.
Molecular Therapy. Advances|July 16, 2026
Pre-existing retinal inflammation exacerbates gene therapy-associated uveitis in more rapidly progressive retinal degenerationMolly C John, Cristina Martinez-Fernandez de la Camara, Ahmed Salman, et al.
Eye (London, England)|September 24, 2011
Pilot randomised controlled trial of face-down positioning following macular hole surgeryC A K Lange, L Membrey, N Ahmad, et al.
BMJ Open|February 22, 2022
How and why do women's groups (WGs) improve the quality of maternal and child health (MCH) care? A systematic review of the literatureKarla Canuto, Robyn Preston, Sam Rannard, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 23, 2025
Alzheimer's Imaging ConsortiumReese A Dunne, Hossein Moein Taghavi, Phillip DiGiacomo, et al.
Eye (London, England)|October 11, 2024
Real-world six-month outcomes in patients switched to faricimab following partial response to anti-VEGF therapy for neovascular age-related macular degeneration and diabetic macular oedemaGrace A Borchert, Christine A Kiire, Niamh M Stone, et al.
Critical Care (London, England)|May 9, 2025
Left ventricular unloading during extracorporeal cardiopulmonary resuscitation: a target trial emulation of the ELSO registryRyan Ruiyang Ling, Ying Chen, Christopher Jer Wei Low, et al.
Molecular Therapy. Advances|June 8, 2026
Efficacy of anti-VEGF single-chain variable fragment AAV-based gene therapy in a laser-induced choroidal neovascularisation mouse modelAhmed Salman, Helen Griffiths, Kamaluddeen Garba, et al.
Frontiers in Toxicology|September 19, 2022
Use of new approach methodologies (NAMs) to meet regulatory requirements for the assessment of industrial chemicals and pesticides for effects on human healthAndreas O Stucki, Tara S Barton-Maclaren, Yadvinder Bhuller, et al.
Pageof 171